20090807 EMEA Announcement of European Medicines Agency priorities for adverse drug reaction research

07/08/09 Announcement of European Medicines Agency priorities for adverse drug reaction research
http://www.emea.europa.eu/pdfs/human/phv/49762409en.pdf

07/08/09 EMEA 2010 Priorities for Drug Safety Research: Long-term effects in children and in young adults of methylphenidate in the treatment of attention deficit hyperactivity disorder (ADHD)
http://www.emea.europa.eu/pdfs/human/phv/49372609en.pdf

07/08/09 EMEA 2010 Priorities for Drug Safety Research: Long term adverse effects of immunomodulators
http://www.emea.europa.eu/pdfs/human/phv/49370509en.pdf

07/08/09 EMEA 2010 Priorities for Drug Safety Research: Long-term adverse skeletal effects of bisphosphonates
http://www.emea.europa.eu/pdfs/human/phv/49371109en.pdf

07/08/09 EMEA 2010 Priorities for Drug Safety Research: Medicine Use in Pregnancy
http://www.emea.europa.eu/pdfs/human/phv/49372409en.pdf

07/08/09 EMEA 2010 Priorities for Drug Safety Research: Suicidal behaviour in relation to certain drug use
http://www.emea.europa.eu/pdfs/human/phv/49379809en.pdf

07/08/09 EMEA 2010 Priorities for Drug Safety Research: Safety aspects of antipsychotics in demented patients
http://www.emea.europa.eu/pdfs/human/phv/49373009en.pdf